“heart-disease” Archives

Entry Author Date Location
San Diego’s Celladon Extends Round to $53M, Opens European Office 05/08/12 San Diego
The Thinking Behind Domain’s $760M Life Sciences Deal in Russia 03/07/12 San Diego
Celladon Raises $43M, Wins Fast-Track Status for Heart Treatment 02/15/12 San Diego
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
CircuLite Pulls in $30M for Heart Device 11/30/11 New York
Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News 07/21/11 San Diego
Celladon Raises $400K 07/14/11 San Diego
Who’s Going to Pay for Future Drug Development? (Part 1) 03/22/11 National
What’s Brewing at Massive Health? A Chat with Newly Funded Co-Founders Sutha Kamal and Aza Raskin 02/02/11 San Francisco
Minnow Raises $4.7M Under New CEO 10/21/10 San Diego
InfraReDx Gets $21M to Launch Coronary Imaging System 10/12/10 Boston
Sequel Raises $1.4M 09/09/10 San Diego
Insilicos Gets $1.2M NIH Grant 09/07/10 Seattle
Genzyme, Isis Cholesterol Drug Passes Pair of Clinical Trials; Shares Fall Anyway 08/04/10 Boston
Where Will the New Disease Treatments Come From a Decade From Now? 07/15/10 San Francisco
Cooking with the Genzyme Recipe: New Players Funding Rare Disease Drugs in Boston 04/12/10 Boston
Ascent Changes to Anchor 03/30/10 Boston
Ischemix Faces Moment of Truth with Mid-Stage Heart Drug Trial 03/16/10 Boston
Sequel Pharmaceuticals’ CEO on How to Start a Biotech and Sell it For a Bundle, and Repeat 10/28/09 San Diego
Accumetrics Gunning To Be the Medical Diagnostics Standard for Managing Cardiovascular Disease 06/19/09 San Diego
Molecular Insight Names Peters CEO 05/13/09 Boston
Acusphere Cuts 40 Jobs 03/04/09 Boston
Isis Inches Closer Toward Profitability 02/25/09 San Diego
HeartWare Takes $282M Buyout 02/13/09 Boston
Imaging Agent for Early Detection of Heart Disease, From Molecular Insight, Reaches Goal 12/23/08 Boston
Epix Wins FDA Approval of Vasovist 12/22/08 Boston
FDA Panel Votes Down Acusphere Drug 12/10/08 Boston
Acusphere Stock Temporarily Halted During FDA Panel on Heart Imaging Drug 12/10/08 Boston
Isis Pharmaceuticals’ Second Drug Aims to Block Marker of Heart Disease, Inflammation 10/16/08 San Diego
Provasculon, a Biogen-backed Startup, Testing Regenerative Medicine on Hearts 10/09/08 Boston
Page 2 of 3 « previous page · next page »